212 related articles for article (PubMed ID: 20101424)
21. Differential maintenance of cortical and cancellous bone strength following discontinuation of bone-active agents.
Shahnazari M; Yao W; Wang B; Panganiban B; Ritchie RO; Hagar Y; Lane NE
J Bone Miner Res; 2011 Mar; 26(3):569-81. PubMed ID: 20839286
[TBL] [Abstract][Full Text] [Related]
22. Effects of alendronate and alfacalcidol on the femoral bone mass and bone strength in orchidectomized rats.
Iwamoto J; Matsumoto H; Takeda T; Sato Y; Xu E; Yeh JK
Chin J Physiol; 2008 Dec; 51(6):331-7. PubMed ID: 19280876
[TBL] [Abstract][Full Text] [Related]
23. Combined treatment with a traditional Chinese medicine, Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) and alendronate improves bone microstructure in ovariectomized rats.
Chen H; Wu M; Kubo KY
J Ethnopharmacol; 2012 Jun; 142(1):80-5. PubMed ID: 22543171
[TBL] [Abstract][Full Text] [Related]
24. Effect of alendronate on the femoral metaphyseal defect under carbamazepine in ovariectomized rats.
Zhang R; Yang M; Li Y; Liu H; Ren M; Tao ZS
J Orthop Surg Res; 2021 Jan; 16(1):14. PubMed ID: 33407695
[TBL] [Abstract][Full Text] [Related]
25. Effects of sequential osteoporosis treatments on trabecular bone in adult rats with low bone mass.
Amugongo SK; Yao W; Jia J; Lay YA; Dai W; Jiang L; Walsh D; Li CS; Dave NK; Olivera D; Panganiban B; Ritchie RO; Lane NE
Osteoporos Int; 2014 Jun; 25(6):1735-50. PubMed ID: 24722767
[TBL] [Abstract][Full Text] [Related]
26. [Very old patients with osteoporosis should be treated with alendronate].
Shiraki M
Nihon Ronen Igakkai Zasshi; 2006 Jul; 43(4):455-8. PubMed ID: 16937932
[TBL] [Abstract][Full Text] [Related]
27. Once-weekly parathyroid hormone combined with ongoing long-term alendronate treatment promotes osteoporotic fracture healing in ovariectomized rats.
Zhang C; Zhu J; Jia J; Guan Z; Sun T; Zhang W; Yuan W; Wang H; Leng H; Song C
J Orthop Res; 2021 Oct; 39(10):2103-2115. PubMed ID: 33325546
[TBL] [Abstract][Full Text] [Related]
28. Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women.
Hirao M; Hashimoto J; Ando W; Ono T; Yoshikawa H
J Bone Miner Metab; 2008; 26(3):260-4. PubMed ID: 18470667
[TBL] [Abstract][Full Text] [Related]
29. Prior treatment with vitamin K(2) significantly improves the efficacy of risedronate.
Matsumoto Y; Mikuni-Takagaki Y; Kozai Y; Miyagawa K; Naruse K; Wakao H; Kawamata R; Kashima I; Sakurai T
Osteoporos Int; 2009 Nov; 20(11):1863-72. PubMed ID: 19280272
[TBL] [Abstract][Full Text] [Related]
30. Alendronate (ALN) combined with osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats.
Wang Y; Huang P; Tang PF; Chan KM; Li G
J Orthop Surg Res; 2011 Jul; 6():34. PubMed ID: 21752290
[TBL] [Abstract][Full Text] [Related]
31. Odanacatib, effects of 16-month treatment and discontinuation of therapy on bone mass, turnover and strength in the ovariectomized rabbit model of osteopenia.
Duong LT; Crawford R; Scott K; Winkelmann CT; Wu G; Szczerba P; Gentile MA
Bone; 2016 Dec; 93():86-96. PubMed ID: 27639811
[TBL] [Abstract][Full Text] [Related]
32. [Skeletal biomechanical properties improvement in ovariectomized osteoporotic rats of teriparatide was retarded by alendronate].
Li M; Jiao J; Meng XW; Zhou XY; Xing XP; Xia WB; Wang O; Jiang Y; Liu HC; Hu YY
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):104-7. PubMed ID: 16624115
[TBL] [Abstract][Full Text] [Related]
33. Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model.
Saito M; Shiraishi A; Ito M; Sakai S; Hayakawa N; Mihara M; Marumo K
Bone; 2010 Apr; 46(4):1170-9. PubMed ID: 20026440
[TBL] [Abstract][Full Text] [Related]
34. Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation.
Atamaz F; Hepguler S; Akyildiz M; Karasu Z; Kilic M
Osteoporos Int; 2006; 17(6):942-9. PubMed ID: 16550299
[TBL] [Abstract][Full Text] [Related]
35. Single and combined effect of high-frequency loading and bisphosphonate treatment on the bone micro-architecture of ovariectomized rats.
Hatori K; Camargos GV; Chatterjee M; Faot F; Sasaki K; Duyck J; Vandamme K
Osteoporos Int; 2015 Jan; 26(1):303-13. PubMed ID: 25236876
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D status and bone mineral density changes during alendronate treatment in postmenopausal osteoporosis.
Roux C; Binkley N; Boonen S; Kiel DP; Ralston SH; Reginster JY; Pong A; Rosenberg E; Santora A;
Calcif Tissue Int; 2014 Feb; 94(2):153-7. PubMed ID: 23912950
[TBL] [Abstract][Full Text] [Related]
37. Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
Exp Anim; 2006 Jul; 55(4):357-67. PubMed ID: 16880683
[TBL] [Abstract][Full Text] [Related]
38. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
[TBL] [Abstract][Full Text] [Related]
39. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
[TBL] [Abstract][Full Text] [Related]
40. In vivo effects of two novel ALN-EP4a conjugate drugs on bone in the ovariectomized rat model for reversing postmenopausal bone loss.
Hu S; Liu CC; Chen G; Willett T; Young RN; Grynpas MD
Osteoporos Int; 2016 Feb; 27(2):797-808. PubMed ID: 26272313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
